EUVIMEDEUVIMED entdecken
Open Access

Emergence of the natural history of Myhre syndrome: 47 patients evaluated in the Massachusetts General Hospital Myhre Syndrome Clinic (2016–2023)

Angela E Lin iD, Eleanor R Scimone, Robyn P Thom iD, Duraisamy Balaguru, T Bernard Kinane iD, Peter P Moschovis iD, Michael S Cohen, Weizhen Tan, Cole D Hague, Katelyn Dannheim iD, Lynne L Levitsky iD, Evelyn Lilly iD und 28 weitere

American Journal of Medical Genetics Part A · 2024

DOI: 10.1002/ajmg.a.63638 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Angela E Lin und 39 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics and Metabolism, Department of Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Smad4 Protein, Phenotype. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myhre syndrome is an increasingly diagnosed ultrarare condition caused by recurrent germline autosomal dominant de novo variants in SMAD4 . Detailed multispecialty evaluations performed at the Massachusetts General Hospital (MGH) Myhre Syndrome Clinic (2016–2023) and by collaborating specialists have facilitated deep phenotyping, genotyping and natural history analysis. Of 47 patients (four previously reported), most (81%) patients returned to MGH at least once. For patients followed for at least 5 years, symptom progression was observed in all. 55% were female and 9% were older than 18 years at diagnosis. Pathogenic variants in SMAD4 involved protein residues p.Ile500Val (49%), p.Ile500Thr (11%), p.Ile500Leu (2%), and p.Arg496Cys (38%). Individuals with the SMAD4 variant p.Arg496Cys were less likely to have hearing loss, growth restriction, and aortic hypoplasia than the other variant groups. Those with the p.Ile500Thr variant had moderate/severe aortic hypoplasia in three patients (60%), however, the small number ( n = 5) prevented statistical comparison with the other variants. Two deaths reported in this cohort involved complex cardiovascular disease and airway stenosis, respectively. We provide a foundation for ongoing natural history studies and emphasize the need for evidence‐based guidelines in anticipation of disease‐specific therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Smad4 ProteinPhenotypeHumansFemaleMaleChildAdolescentChild, PreschoolAdultInfantIntellectual DisabilityCryptorchidismMassachusettsYoung AdultFaciesGrowth DisordersGenotypeHospitals, GeneralClubfootMutationHand Deformities, Congenital

Stichwörter der Autor:innen

SMAD4 variantsTGF‐β signalingautismconnective tissue diseasehearing lossvasculopathy

Substanzen

Smad4 ProteinSMAD4 protein, human

Autor:innen und Institutionen

  • Medical Genetics and Metabolism, Department of Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Lurie Center for Autism, Mass General for Children, Boston, Massachusetts, USA.
  • Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Pediatric Cardiology, Department of Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Pediatric Pulmonary and Sleep Medicine, Department of Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Pediatric Otorhinolaryngology, Massachusetts Eye and Ear, Boston, Massachusetts, USA.

ORCID-Profile: Angela E Lin, Robyn P Thom, T Bernard Kinane, Peter P Moschovis, Katelyn Dannheim, Lynne L Levitsky, Evelyn Lilly, Daniel V DiGiacomo, Ann M Neumeyer, Mary K Colvin, Jack S Elder, Kenda Alhadid, Otto Rapalino, Aaron T Dorfman, Shaine A Morris, Lisa A Schimmenti, Mark E Lindsay

Förderung

  • NIEHS NIH HHS

Zitieren

APA

Lin, A. E., Scimone, E. R., Thom, R. P., Balaguru, D., Kinane, T. B., Moschovis, P. P., Cohen, M. S., Tan, W., Hague, C. D., Dannheim, K., Levitsky, L. L., Lilly, E., DiGiacomo, D. V., Masse, K. M., Kadzielski, S. M., Zar-Kessler, C. A., Ginns, L. C., Neumeyer, A. M., Colvin, M. K., …, & MGH Myhre Syndrome Study Group (2024). Emergence of the natural history of Myhre syndrome: 47 patients evaluated in the Massachusetts General Hospital Myhre Syndrome Clinic (2016–2023). American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63638

Vancouver

Lin AE, Scimone ER, Thom RP, Balaguru D, Kinane TB, Moschovis PP, et al. Emergence of the natural history of Myhre syndrome: 47 patients evaluated in the Massachusetts General Hospital Myhre Syndrome Clinic (2016–2023). American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63638

BibTeX
@article{Lin2024,
  author = {Lin, Angela E and Scimone, Eleanor R and Thom, Robyn P and Balaguru, Duraisamy and Kinane, T Bernard and Moschovis, Peter P and Cohen, Michael S and Tan, Weizhen and Hague, Cole D and Dannheim, Katelyn and Levitsky, Lynne L and Lilly, Evelyn and DiGiacomo, Daniel V and Masse, Kara M and Kadzielski, Sarah M and Zar-Kessler, Claire A and Ginns, Leo C and Neumeyer, Ann M and Colvin, Mary K and Elder, Jack S and Learn, Christopher P and Mou, Hongmei and Weagle, Kathryn M and Buch, Karen A and Butler, William E and Alhadid, Kenda and Musolino, Patricia L and Sultana, Sadia and Bandyopadhyay, Dhrubajyoti and Rapalino, Otto and Peacock, Zachary S and Chou, Elizabeth L and Heidary, Gena and Dorfman, Aaron T and Morris, Shaine A and Bergin, James D and Rayment, Jonathan H and Schimmenti, Lisa A and Lindsay, Mark E and MGH Myhre Syndrome Study Group, MGH Myhre Syndrome Study Group},
  title = {Emergence of the natural history of Myhre syndrome: 47 patients evaluated in the Massachusetts General Hospital Myhre Syndrome Clinic (2016–2023)},
  journal = {American Journal of Medical Genetics Part A},
  year = {2024},
  doi = {10.1002/ajmg.a.63638}
}
Kostenlos starten →